Abstract |
We developed an approach that increases CD4+CD25+ regulatory T-cell potency by antigen-specifically redirecting them against pathologic T lymphocytes. The regulatory cells are transgenically modified with chimeric receptors that link antigen-major histocompatibility complex (MHC) extracellular and transmembrane domains with the cytoplasmic signaling tail of T-cell receptor zeta (TCR-zeta). The receptors' antigen-MHC recognizes the TCR of cognate T lymphocytes. Receptor engagement stimulates the receptor-modified T cell (RMTC) through the linked zeta chain. CD4+CD25+ RMTCs expressing a myelin basic protein (MBP) 89-101-IAs-zeta receptor, unlike unmodified CD4+CD25+ T cells or CD4+CD25- RMTCs, prevented and treated experimental allergic encephalomyelitis (EAE) induced with MBP89-101. The RMTCs were effective even after the autoreactive T-cell repertoire had diversified to include specificities not directly targeted by the chimeric receptor. Remissions were sustained and mortality was decreased from more than 50% to 0%. These results provide proof of principal for a novel approach to enforce the interaction of regulatory and pathologic T lymphocytes, thereby facilitating the treatment of autoimmune disease.
|
Authors | Divya J Mekala, Terrence L Geiger |
Journal | Blood
(Blood)
Vol. 105
Issue 5
Pg. 2090-2
(Mar 01 2005)
ISSN: 0006-4971 [Print] United States |
PMID | 15528313
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Membrane Proteins
- Myelin Basic Protein
- Peptide Fragments
- Receptors, Antigen, T-Cell
- Receptors, Interleukin-2
- antigen T cell receptor, zeta chain
- myelin basic protein 89-101
|
Topics |
- Adoptive Transfer
(methods)
- Animals
- CD4-Positive T-Lymphocytes
(transplantation)
- Cells, Cultured
- Encephalomyelitis, Autoimmune, Experimental
(therapy)
- Female
- Membrane Proteins
(immunology)
- Mice
- Mice, Transgenic
- Myelin Basic Protein
(immunology)
- Peptide Fragments
(immunology)
- Receptors, Antigen, T-Cell
(immunology)
- Receptors, Interleukin-2
- T-Cell Antigen Receptor Specificity
|